Novo Nordisk A/S (NONOF)
38.93
+0.03
(+0.07%)
USD |
OTCM |
Oct 26, 16:00
Novo Nordisk Price to Book Value : 5.085 for Oct. 26, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 5.085 |
| October 23, 2026 | 5.081 |
| October 22, 2026 | 5.151 |
| October 21, 2026 | 5.081 |
| October 20, 2026 | 5.090 |
| October 19, 2026 | 4.996 |
| October 16, 2026 | 5.073 |
| October 15, 2026 | 5.156 |
| October 14, 2026 | 4.923 |
| October 13, 2026 | 4.958 |
| October 12, 2026 | 5.067 |
| October 09, 2026 | 4.983 |
| October 08, 2026 | 5.000 |
| October 07, 2026 | 4.936 |
| October 06, 2026 | 4.884 |
| October 05, 2026 | 4.877 |
| October 02, 2026 | 4.834 |
| October 01, 2026 | 4.882 |
| September 30, 2026 | 4.983 |
| September 29, 2026 | 5.008 |
| September 28, 2026 | 5.013 |
| September 25, 2026 | 5.049 |
| September 24, 2026 | 5.016 |
| September 23, 2026 | 4.996 |
| September 22, 2026 | 5.136 |
| Date | Value |
|---|---|
| September 21, 2026 | 5.214 |
| September 18, 2026 | 5.566 |
| September 17, 2026 | 5.486 |
| September 16, 2026 | 5.428 |
| September 15, 2026 | 5.540 |
| September 14, 2026 | 5.704 |
| September 11, 2026 | 5.641 |
| September 10, 2026 | 5.766 |
| September 09, 2026 | 5.808 |
| September 08, 2026 | 5.936 |
| September 04, 2026 | 6.048 |
| September 03, 2026 | 6.074 |
| September 02, 2026 | 6.120 |
| September 01, 2026 | 5.924 |
| August 31, 2026 | 5.910 |
| August 28, 2026 | 5.880 |
| August 27, 2026 | 6.029 |
| August 26, 2026 | 6.19 |
| August 25, 2026 | 6.286 |
| August 24, 2026 | 6.139 |
| August 21, 2026 | 6.114 |
| August 20, 2026 | 6.052 |
| August 19, 2026 | 5.930 |
| August 18, 2026 | 5.867 |
| August 17, 2026 | 5.892 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 35.59 |
| ALK-Abello A/S | 7.627 |
| H. Lundbeck A/S | 1.654 |
| AstraZeneca PLC | 11.13 |
| GSK Plc | 4.412 |
Price to Book Value Related Metrics
| PE Ratio | 9.514 |
| PS Ratio | 3.363 |
| PEG Ratio | 0.755 |
| Price to Free Cash Flow | 23.48 |
| Price | 38.93 |
| Earnings Yield | 10.51% |
| Market Cap | 172.09B |
| PEGY Ratio | 0.5523 |
| Operating PE Ratio | 7.412 |
| Normalized PE Ratio | 9.145 |